Physics & Astronomy
leukemias
100%
tyrosine
83%
inhibitors
80%
perturbation
46%
cells
37%
drugs
19%
therapy
18%
oncogenes
17%
pathogenesis
15%
toxicity
12%
genes
11%
retarding
7%
Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
72%
Myeloid Cells
70%
Protein-Tyrosine Kinases
42%
Dasatinib
21%
Imatinib Mesylate
17%
Therapeutics
11%
Gene Knockdown Techniques
10%
K562 Cells
9%
p38 Mitogen-Activated Protein Kinases
7%
Hematologic Neoplasms
7%
Isoenzymes
7%
Oncogenes
7%
Pharmaceutical Preparations
6%
Leukemia
6%
Growth
3%
Chemical Compounds
Tyrosine Kinase Inhibitor
96%
Tyrosine
31%
Imatinib
25%
Drug
18%
Application
10%
Engineering & Materials Science
Cytotoxicity
51%
Toxicity
40%
Genes
32%